Blue Dye 2 vs Green Dye 3: which is worse?

What is Blue Dye 2?

Blue Dye 2 (Indigotine/Indigo Carmine) is a synthetic disulfonated derivative of indigo. Unlike natural indigo from the indigo plant, the FD&C version is synthetically manufactured from petroleum. It produces a dark royal blue to indigo color and is used in food, pharmaceuticals, and medical diagnostics.

What is Green Dye 3?

Green Dye 3 (Fast Green FCF) is a synthetic blue-green triarylmethane dye similar to Blue Dye 1. It produces a sea-green color and is among the least used certified US food dyes. Its chemical formula is C37H34N2Na2O10S3.

Documented risks

Blue Dye 2: Animal studies conducted in the 1980s found that high-dose Blue Dye 2 caused brain tumors in male rats. An NTP bioassay (1987) found statistically significant increases in brain gliomas (astrocytomas) in male rats given high doses. The FDA reviewed these findings and determined that the doses far exceeded typical human dietary exposure. Nonetheless, the tumor finding remains in the scientific record as a concerning data point. EFSA's 2010 safety evaluation of Indigo Carmine (E132) reached an unusual conclusion: it could not establish an ADI due to data limitations, including the brain tumor findings. This means EFSA adopted an implicit conservative position — it neither declared Blue 2 safe nor formally banned it, but the absence of an established ADI signals scientific uncertainty. In medical diagnostic use, high intravenous doses of Indigo Carmine can cause hypertension, bradycardia, and in rare cases anaphylaxis. These are dose-specific clinical pharmacological effects, not relevant to dietary consumption at food use levels. Blue 2 was not included in the 2007 Lancet hyperactivity study. Limited direct research links Blue 2 to behavioral effects. The FDA's April 2025 announcement includes Blue 2 in the class of petroleum-based synthetic dyes to be phased out of the US food supply, reflecting updated policy on the category rather than specific new Blue 2 toxicity data.

Green Dye 3: Green Dye 3 has a limited safety database compared to other certified food dyes, partly due to its infrequent use. A 1981 NTP bioassay (Technical Report 27) found statistically significant increases in urinary bladder tumors in male mice at high doses. The FDA reviewed these findings and, as with Blue 2, concluded the doses far exceeded typical human dietary exposure. Green 3 is not approved in the EU — under the EU's positive list system, only specifically approved additives may be used. Since Green 3 is not on the positive list, it is effectively banned. EFSA has not conducted a formal re-evaluation because it is not authorized for EU use. Hypersensitivity reactions have been reported. Like other synthetic triarylmethane dyes, Green 3 may cause contact dermatitis. The FDA's April 2025 phase-out announcement includes Green 3 among the eight petroleum-based synthetic dyes to be removed from the US food supply. Its already limited use means this phase-out has minimal market impact compared to Red 40 or Yellow 5.